
Indica Labs is a global leader in AI-powered digital pathology, offering a suite of software and services to revolutionize quantitative evaluation and management of whole slide images. Their flagship HALO platform, including HALO AI for trainable AI and HALO Link for collaborative image management, supports both research and clinical diagnostics. Products like HALO AP and HALO AP Dx are FDA-cleared for primary diagnosis. Indica Labs focuses on open pathology, performance, scalability, and ease-of-use, serving pharma companies, diagnostic labs, hospitals, and research organizations to advance scientific discovery and patient care.

Indica Labs is a global leader in AI-powered digital pathology, offering a suite of software and services to revolutionize quantitative evaluation and management of whole slide images. Their flagship HALO platform, including HALO AI for trainable AI and HALO Link for collaborative image management, supports both research and clinical diagnostics. Products like HALO AP and HALO AP Dx are FDA-cleared for primary diagnosis. Indica Labs focuses on open pathology, performance, scalability, and ease-of-use, serving pharma companies, diagnostic labs, hospitals, and research organizations to advance scientific discovery and patient care.
Founded: 2011
Headquarters: Albuquerque/Corrales, New Mexico
Core product: HALO family (digital pathology image analysis and management)
Regulatory status: Some products FDA-cleared / CE‑IVD marked
Recent disclosed funding: Grant from New Mexico Economic Development Department (Jun 3, 2022)
| Company |
|---|
Digital pathology image analysis, AI-driven quantitative pathology, and image management for research and clinical diagnostics.
2011
Biotechnology
Single disclosed grant round per available records